Inscrição na biblioteca: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

Publicou 6 edições por ano

ISSN Imprimir: 0743-4863

ISSN On-line: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Pulmonary Drug Delivery Systems: Recent Developments and Prospects

Volume 19, Edição 4-5, 2002, 64 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v19.i45.40
Get accessGet access

RESUMO

Targeting drug delivery into the lungs has become one of the most important aspects of systemic or local drug delivery systems. Consequently, in the last few years, techniques and new drug delivery devices intended to deliver drugs into the lungs have been widely developed. Currently, the main drug targeting regimens include direct application of a drug into the lungs, mostly by inhalation therapy using either pressurized metered dose inhalers (pMDI) or dry powder inhalers (DPI). Intratracheal administration is commonly used as a first approach in lung drug delivery in vivo. To convey a sufficient dose of drug to the lungs, suitable drug arriers are required. These can be either solid, liquid, or gaseous excipients. Liposomes, nano- and microparticles, cyclodextrins, microemulsions, micelles, suspensions, or solutions are all examples of this type of pharmaceutical carrier that have been successfully used to target drugs into the lungs. The use of microreservoir-type systems offers clear advantages, such as high loading capacity and the possibility of controlling size and permeability, and thus of controlling the release kinetics of the drugs from the carrier systems. These systems make it possible to use relatively small numbers of vector molecules to deliver substantial amounts of a drug to the target. This review discusses the drug carriers administered or intended to be administered into the lungs. The transition to CFC-free inhalers and drug delivery systems formulated with new propellants are also discussed. Finally, in addition to the various advances made in the field of pulmonary-route administration, we describe new systems based on per. uorooctyl bromide, which guarantee oxygen delivery in the event of respiratory distress and drug delivery into the lungs.

CITADO POR
  1. Hamishehkar Hamed, Emami Jaber, Najafabadi Abdolhossien Rouholamini, Gilani Kambiz, Minaiyan Mohsen, Hassanzadeh Kambiz, Mahdavi Hamid, Koohsoltani Maryam, Nokhodchi Ali, Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats, Biopharmaceutics & Drug Disposition, 2010. Crossref

  2. Paul Alison, Griffiths Peter C, Rogueda Philippe G, Towards an understanding of adsorption behaviour in non-aqueous systems: adsorption of poly(vinyl pyrrolidone) and poly(ethylene glycol) onto silica from 2H, 3H-perfluoropentane, Journal of Pharmacy and Pharmacology, 57, 11, 2010. Crossref

  3. Tam Jasmine M., McConville Jason T., Williams Robert O., Johnston Keith P., Amorphous cyclosporin nanodispersions for enhanced pulmonary deposition and dissolution, Journal of Pharmaceutical Sciences, 97, 11, 2008. Crossref

  4. Yang Jerry Z., Young Anthony L., Chiang Po-Chang, Thurston Archie, Pretzer Denise K., Fluticasone and budesonide nanosuspensions for pulmonary delivery: Preparation, characterization, and pharmacokinetic studies, Journal of Pharmaceutical Sciences, 97, 11, 2008. Crossref

  5. Rogueda Philippe GA, Traini Daniela, The nanoscale in pulmonary delivery. Part 1: deposition, fate, toxicology and effects, Expert Opinion on Drug Delivery, 4, 6, 2007. Crossref

  6. Choi Hak Soo, Ashitate Yoshitomo, Lee Jeong Heon, Kim Soon Hee, Matsui Aya, Insin Numpon, Bawendi Moungi G, Semmler-Behnke Manuela, Frangioni John V, Tsuda Akira, Rapid translocation of nanoparticles from the lung airspaces to the body, Nature Biotechnology, 28, 12, 2010. Crossref

  7. Zheng Jianheng, Zhang Ge, Lu Yang, Fang Fang, He Jiake, Li Ning, Talbi Amer, Zhang Ying, Tang Yue, Zhu Jiabi, Chen Xijing, Effect of Pulmonary Surfactant and Phospholipid Hexadecanol Tyloxapol on Recombinant Human-Insulin Absorption from Intratracheally Administered Dry Powders in Diabetic Rats, Chemical and Pharmaceutical Bulletin, 58, 12, 2010. Crossref

  8. El‐Sherbiny Ibrahim M., McGill Shayna, Smyth Hugh D.C., Swellable microparticles as carriers for sustained pulmonary drug delivery, Journal of Pharmaceutical Sciences, 99, 5, 2010. Crossref

  9. Oh Phil, Borgström Per, Witkiewicz Halina, Li Yan, Borgström Bengt J, Chrastina Adrian, Iwata Koji, Zinn Kurt R, Baldwin Richard, Testa Jacqueline E, Schnitzer Jan E, Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung, Nature Biotechnology, 25, 3, 2007. Crossref

  10. Engstrom Josh D., Tam Jasmine M., Miller Maria A., Williams Robert O., Johnston Keith P., Templated Open Flocs of Nanorods for Enhanced Pulmonary Delivery with Pressurized Metered Dose Inhalers, Pharmaceutical Research, 26, 1, 2009. Crossref

  11. Selvam Parthiban, Chokshi Udayan, Gouch Ayanna, Wu Libo, Porcar Lionel, da Rocha Sandro R. P., Ethoxylated copolymersurfactants for the HFA134a–water interface: interfacial activity, aggregate microstructure and biomolecule uptake, Soft Matter, 4, 2, 2008. Crossref

  12. Rogueda Philippe, Novel hydrofluoroalkane suspension formulations for respiratory drug delivery, Expert Opinion on Drug Delivery, 2, 4, 2005. Crossref

  13. Tam Jasmine M., Engstrom Josh D., Ferrer Domingo, Williams Robert O., Johnston Keith P., Templated Open Flocs of Anisotropic Particles for Pulmonary Delivery with Pressurized Metered Dose Inhalers, Journal of Pharmaceutical Sciences, 99, 7, 2010. Crossref

  14. Wessman Per, Edwards Katarina, Mahlin Denny, Structural effects caused by spray‐ and freeze‐drying of liposomes and bilayer disks, Journal of Pharmaceutical Sciences, 99, 4, 2010. Crossref

  15. Wu Libo, Bharatwaj Balaji, Panyam Jayanth, da Rocha Sandro R. P., Core–shell Particles for the Dispersion of Small Polar Drugs and Biomolecules in Hydrofluoroalkane Propellants, Pharmaceutical Research, 25, 2, 2008. Crossref

  16. Yang Yu-Tsai, Chen Chin-Tin, Yang Jen-Chang, Tsai Tsuimin, Spray-Dried Microparticles Containing Polymeric Micelles Encapsulating Hematoporphyrin, The AAPS Journal, 12, 2, 2010. Crossref

  17. Bosselmann Stephanie, Williams Robert O., Has nanotechnology led to improved therapeutic outcomes?, Drug Development and Industrial Pharmacy, 38, 2, 2012. Crossref

  18. Hamishehkar Hamed, Emami Jaber, Najafabadi Abdolhossien Rouholamini, Gilani Kambiz, Minaiyan Mohsen, Mahdavi Hamid, Nokhodchi Ali, Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin, International Journal of Pharmaceutics, 389, 1-2, 2010. Crossref

  19. Akbulut Mustafa, D’Addio Suzanne M, Gindy Marian E, Prud’homme Robert K, Novel methods of targeted drug delivery: the potential of multifunctional nanoparticles, Expert Review of Clinical Pharmacology, 2, 3, 2009. Crossref

  20. Nassimi M., Schleh C., Lauenstein H.D., Hussein R., Hoymann H.G., Koch W., Pohlmann G., Krug N., Sewald K., Rittinghausen S., Braun A., Müller-Goymann C., A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung, European Journal of Pharmaceutics and Biopharmaceutics, 75, 2, 2010. Crossref

  21. Wu Libo, Al-Haydari Mariam, da Rocha Sandro R.P., Novel propellant-driven inhalation formulations: Engineering polar drug particles with surface-trapped hydrofluoroalkane-philes, European Journal of Pharmaceutical Sciences, 33, 2, 2008. Crossref

  22. Huang Yi-You, Wang Ching-Hua, Pulmonary delivery of insulin by liposomal carriers, Journal of Controlled Release, 113, 1, 2006. Crossref

  23. Sham Jeffrey O.-H, Zhang Yu, Finlay Warren H, Roa Wilson H, Löbenberg Raimar, Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung, International Journal of Pharmaceutics, 269, 2, 2004. Crossref

  24. Yang Wei, Peters Jay I., Williams Robert O., Inhaled nanoparticles—A current review, International Journal of Pharmaceutics, 356, 1-2, 2008. Crossref

  25. Grenha Ana, Seijo Begoña, Remuñán-López Carmen, Microencapsulated chitosan nanoparticles for lung protein delivery, European Journal of Pharmaceutical Sciences, 25, 4-5, 2005. Crossref

  26. Beck-Broichsitter Moritz, Schmehl Thomas, Seeger Werner, Gessler Tobias, Pulmonary Drug Delivery with Nanoparticles, in Nanomedicine in Health and Disease, 2011. Crossref

  27. Selvam Parthiban, Bharatwaj Balaji, Porcar Lionel, da Rocha Sandro R.P., Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics, International Journal of Pharmaceutics, 422, 1-2, 2012. Crossref

  28. Azarmi Shirzad, Roa Wilson H., Löbenberg Raimar, Targeted delivery of nanoparticles for the treatment of lung diseases, Advanced Drug Delivery Reviews, 60, 8, 2008. Crossref

  29. Cook Robert O., Pannu Rupi K., Kellaway Ian W., Novel sustained release microspheres for pulmonary drug delivery, Journal of Controlled Release, 104, 1, 2005. Crossref

  30. Swift Robert V., Amaro Rommie E., Modeling the pharmacodynamics of passive membrane permeability, Journal of Computer-Aided Molecular Design, 25, 11, 2011. Crossref

  31. Forbes Ben, Ehrhardt Carsten, Human respiratory epithelial cell culture for drug delivery applications, European Journal of Pharmaceutics and Biopharmaceutics, 60, 2, 2005. Crossref

  32. Beck-Broichsitter Moritz, Schmehl Thomas, Seeger Werner, Gessler Tobias, Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models, Journal of Nanomaterials, 2011, 2011. Crossref

  33. Jaspart Séverine, Bertholet Pascal, Piel Géraldine, Dogné Jean-Michel, Delattre Luc, Evrard Brigitte, Solid lipid microparticles as a sustained release system for pulmonary drug delivery, European Journal of Pharmaceutics and Biopharmaceutics, 65, 1, 2007. Crossref

  34. Arima Hidetoshi, Motoyama Keiichi, Irie Tetsumi, Recent Findings on Safety Profiles of Cyclodextrins, Cyclodextrin Conjugates, and Polypseudorotaxanes, in Cyclodextrins in Pharmaceutics, Cosmetics, and Biomedicine, 2011. Crossref

  35. Grenha Ana, Grainger Christopher I., Dailey Lea Ann, Seijo Begoña, Martin Gary P., Remuñán-López Carmen, Forbes Ben, Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro, European Journal of Pharmaceutical Sciences, 31, 2, 2007. Crossref

  36. Al-Qadi Sonia, Grenha Ana, Remuñán-López Carmen, Microspheres loaded with polysaccharide nanoparticles for pulmonary delivery: Preparation, structure and surface analysis, Carbohydrate Polymers, 86, 1, 2011. Crossref

  37. Griffiths Peter C., Côte Marie, Rogueda Philippe G.A., Elaborating the phase behaviour of ethylene oxide oligomers and analogues in 2H, 3H-perfluoropentane, International Journal of Pharmaceutics, 362, 1-2, 2008. Crossref

  38. Mady Mohsen M., Elshemey Wael M., Interaction of dipalmitoyl phosphatidylcholine (DPPC) liposomes and insulin, Molecular Physics, 109, 12, 2011. Crossref

  39. Courrier H.M., Pons F., Lessinger J.M., Frossard N., Krafft M.P., Vandamme Th.F., In vivo evaluation of a reverse water-in-fluorocarbon emulsion stabilized with a semifluorinated amphiphile as a drug delivery system through the pulmonary route, International Journal of Pharmaceutics, 282, 1-2, 2004. Crossref

  40. Sebti Thami, Amighi Karim, Preparation and in vitro evaluation of lipidic carriers and fillers for inhalation, European Journal of Pharmaceutics and Biopharmaceutics, 63, 1, 2006. Crossref

  41. Yang Yan, Bajaj Nimisha, Xu Peisheng, Ohn Kimberly, Tsifansky Michael D., Yeo Yoon, Development of highly porous large PLGA microparticles for pulmonary drug delivery, Biomaterials, 30, 10, 2009. Crossref

  42. Chokshi Udayan, Selvam Parthiban, Porcar Lionel, da Rocha Sandro R.P., Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles, International Journal of Pharmaceutics, 369, 1-2, 2009. Crossref

  43. Grenha Ana, Remuñán-López Carmen, Carvalho Edison L.S., Seijo Begoña, Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins, European Journal of Pharmaceutics and Biopharmaceutics, 69, 1, 2008. Crossref

  44. Yang Wei, Tam Jasmine, Miller Dave A., Zhou Jiping, McConville Jason T., Johnston Keith P., Williams Robert O., High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers, International Journal of Pharmaceutics, 361, 1-2, 2008. Crossref

  45. Hughes Gareth A., Nanostructure-mediated drug delivery, Nanomedicine: Nanotechnology, Biology and Medicine, 1, 1, 2005. Crossref

  46. Kogan Anna, Garti Nissim, Microemulsions as transdermal drug delivery vehicles, Advances in Colloid and Interface Science, 123-126, 2006. Crossref

  47. Hasirci V., Vrana E., Zorlutuna P., Ndreu A., Yilgor P., Basmanav F. B., Aydin E., Nanobiomaterials: a review of the existing science and technology, and new approaches, Journal of Biomaterials Science, Polymer Edition, 17, 11, 2006. Crossref

  48. Hughes Gareth A., Nanostructure-Mediated Drug Delivery, Disease-a-Month, 51, 6, 2005. Crossref

  49. Beck-Broichsitter Moritz, Merkel Olivia M., Kissel Thomas, Controlled pulmonary drug and gene delivery using polymeric nano-carriers, Journal of Controlled Release, 161, 2, 2012. Crossref

  50. Clark A.R., Wolff R.K., Eldon M.A., Dwivedi S.K., The Application of Pulmonary Inhalation Technology to Drug Discovery, in Annual Reports in Medicinal Chemistry Volume 41, 41, 2006. Crossref

  51. Beck-Broichsitter Moritz, Kleimann Pia, Schmehl Thomas, Betz Thomas, Bakowsky Udo, Kissel Thomas, Seeger Werner, Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers, European Journal of Pharmaceutics and Biopharmaceutics, 82, 2, 2012. Crossref

  52. Patel Gaurang, Chougule Mahavir, Singh Mandip, Misra Ambikanandan, Nanoliposomal Dry Powder Formulations, in Liposomes, Part F, 464, 2009. Crossref

  53. Palanikumar L., Ramasamy S., Hariharan G., Balachandran C., Influence of particle size of nano zinc oxide on the controlled delivery of Amoxicillin, Applied Nanoscience, 3, 5, 2013. Crossref

  54. Khosravi-Darani Kianoush, Pardakhty Abbas, Honarpisheh Hamid, Rao V.S.N. Malleswara, Mozafari M. Reza, The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy, Micron, 38, 8, 2007. Crossref

  55. Jaafar-Maalej Chiraz, Elaissari Abdelhamid, Fessi Hatem, Lipid-based carriers: manufacturing and applications for pulmonary route, Expert Opinion on Drug Delivery, 9, 9, 2012. Crossref

  56. Scalia Santo, Salama Rania, Young Paul, Traini Daniela, Preparation andin vitroevaluation of salbutamol-loaded lipid microparticles for sustained release pulmonary therapy, Journal of Microencapsulation, 29, 3, 2012. Crossref

  57. Shekunov Boris Y., Chattopadhyay Pratibhash, Tong Henry H. Y., Chow Albert H. L., Particle Size Analysis in Pharmaceutics: Principles, Methods and Applications, Pharmaceutical Research, 24, 2, 2007. Crossref

  58. Beck-Broichsitter Moritz, Schmehl Thomas, Gessler Tobias, Seeger Werner, Kissel Thomas, Development of a biodegradable nanoparticle platform for sildenafil: Formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters, Journal of Controlled Release, 157, 3, 2012. Crossref

  59. Kamalha Edwin, Shi Xiangyang, Mwasiagi Josphat I., Zeng Yongchun, Nanotechnology and carbon nanotubes; A review of potential in drug delivery, Macromolecular Research, 20, 9, 2012. Crossref

  60. Pandey Sunil, Oza Goldie, Mewada Ashmi, Shah Ritu, Thakur Mukeshchand, Sharon Madhuri, Folic acid mediated synaphic delivery of doxorubicin using biogenic gold nanoparticles anchored to biological linkers, Journal of Materials Chemistry B, 1, 9, 2013. Crossref

  61. Saleem Imran Y., Smyth Hugh D. C., Tuning Aerosol Particle Size Distribution of Metered Dose Inhalers Using Cosolvents and Surfactants, BioMed Research International, 2013, 2013. Crossref

  62. Nanoparticles in Drug Delivery Systems, in Nanomedicine in Drug Delivery, 2013. Crossref

  63. Lee Eung-Seok, Han Jong-min, Kim Min-Hee, Namgung Uk, Yeo Yoon, Park Yang-Chun, Effects of Inhalable Microparticles of on Chronic Obstructive Pulmonary Disease in a Mouse Model, Journal of Korean Medicine, 34, 3, 2013. Crossref

  64. Pandey Sunil, Shah Ritu, Mewada Ashmi, Thakur Mukeshchand, Oza Goldie, Sharon Madhuri, Gold nanorods mediated controlled release of doxorubicin: nano-needles for efficient drug delivery, Journal of Materials Science: Materials in Medicine, 24, 7, 2013. Crossref

  65. Pandey Sunil, Thakur Mukeshchand, Shah Ritu, Oza Goldie, Mewada Ashmi, Sharon Madhuri, A comparative study of economical separation and aggregation properties of biologically capped and thiol functionalized gold nanoparticles: Selecting the eco-friendly trojan horses for biological applications, Colloids and Surfaces B: Biointerfaces, 109, 2013. Crossref

  66. Ali Mohammed, Pulmonary Drug Delivery, in Handbook of Non-Invasive Drug Delivery Systems, 2010. Crossref

  67. Maya S., Kumar Lekshmi G., Sarmento Bruno, Sanoj Rejinold N., Menon Deepthy, Nair Shantikumar V., Jayakumar R., Cetuximab conjugated O-carboxymethyl chitosan nanoparticles for targeting EGFR overexpressing cancer cells, Carbohydrate Polymers, 93, 2, 2013. Crossref

  68. Traini Daniela, Inhalation Drug Delivery, in Inhalation Drug Delivery, 2013. Crossref

  69. Jia Feng, Liu Xunpei, Li Linheng, Mallapragada Surya, Narasimhan Balaji, Wang Qun, Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents, Journal of Controlled Release, 172, 3, 2013. Crossref

  70. Mahajan Hitendra S., Gundare Sadanand A., Preparation, characterization and pulmonary pharmacokinetics of xyloglucan microspheres as dry powder inhalation, Carbohydrate Polymers, 102, 2014. Crossref

  71. Dosage Form Considerations in Preformulation, in Handbook of Preformulation, 2006. Crossref

  72. Pandey Sunil, Thakur Mukeshchand, Mewada Ashmi, Anjarlekar Dhanashree, Mishra Neeraj, Sharon Madhuri, Carbon dots functionalized gold nanorod mediated delivery of doxorubicin: tri-functional nano-worms for drug delivery, photothermal therapy and bioimaging, Journal of Materials Chemistry B, 1, 38, 2013. Crossref

  73. Pathak Yashwant, Thassu Deepak, Deleers Michel, Pharmaceutical Applications of Nanoparticulate Drug-Delivery Systems, in Nanoparticulate Drug Delivery Systems, 20075578, 2007. Crossref

  74. Beck-Broichsitter Moritz, Prüfer Nadine, Oesterheld Nina, Seeger Werner, Schmehl Thomas, Nebulization of Active Pharmaceutical Ingredients with the eFlow®rapid: Impact of Formulation Variables on Aerodynamic Characteristics, Journal of Pharmaceutical Sciences, 103, 8, 2014. Crossref

  75. Haghi Mehra, Saadat Alessandro, Zhu Bing, Colombo Gaia, King Gregory, Young Paul M., Traini Daniela, Immunomodulatory Effects of a Low-Dose Clarithromycin-Based Macrolide Solution Pressurised Metered Dose Inhaler, Pharmaceutical Research, 32, 6, 2015. Crossref

  76. Ali Mohamed Ehab, Lamprecht Alf, Spray freeze drying for dry powder inhalation of nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, 87, 3, 2014. Crossref

  77. Dhand Chetna, Prabhakaran Molamma P., Beuerman Roger W., Lakshminarayanan R., Dwivedi Neeraj, Ramakrishna Seeram, Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery, RSC Adv., 4, 62, 2014. Crossref

  78. Shan Ziyun, Tan Yinhe, Qin Lingzhen, Li Ge, Pan Xin, Wang Zhouhua, Yu Xiu, Wang Qinruo, Wu Chuanbin, Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants, International Journal of Pharmaceutics, 466, 1-2, 2014. Crossref

  79. Good Clinical Practice, in Handbook of Bioequivalence Testing, 2014. Crossref

  80. Cocks Elizabeth, Somavarapu Satyanarayana, Alpar Oya, Greenleaf David, Influence of Suspension Stabilisers on the Delivery of Protein-Loaded Porous Poly (DL-Lactide-co-Glycolide) (PLGA) Microparticles via Pressurised Metered Dose Inhaler (pMDI), Pharmaceutical Research, 31, 8, 2014. Crossref

  81. Ali Mohamed Ehab, McConville Jason T, Lamprecht Alf, Pulmonary delivery of anti-inflammatory agents, Expert Opinion on Drug Delivery, 12, 6, 2015. Crossref

  82. Grenha A., Al-Qadi S., Seijo B., Remuñán-López C., The potential of chitosan for pulmonary drug delivery, Journal of Drug Delivery Science and Technology, 20, 1, 2010. Crossref

  83. Weers Jeffry G., Miller Danforth P., Formulation Design of Dry Powders for Inhalation, Journal of Pharmaceutical Sciences, 104, 10, 2015. Crossref

  84. Li Hao-Ying, Neill Helen, Innocent Rebecca, Seville Peter, Williamson Ian, Birchall James C., Enhanced Dispersibility and Deposition of Spray-dried Powders for Pulmonary Gene Therapy, Journal of Drug Targeting, 11, 7, 2003. Crossref

  85. Xu Caina, Tian Huayu, Sun Hai, Jiao Zixue, Zhang Ying, Chen Xuesi, A pH sensitive co-delivery system of siRNA and doxorubicin for pulmonary administration to B16F10 metastatic lung cancer, RSC Advances, 5, 125, 2015. Crossref

  86. Chen Ai-Zheng, Tang Na, Wang Shi-Bin, Kang Yong-Qiang, Song Hu-Fan, Insulin-loaded poly-l-lactide porous microspheres prepared in supercritical CO2 for pulmonary drug delivery, The Journal of Supercritical Fluids, 101, 2015. Crossref

  87. Verma Rahul K., Ibrahim Mariam, Garcia-Contreras Lucila, Lung Anatomy and Physiology and Their Implications for Pulmonary Drug Delivery, in Pulmonary Drug Delivery, 2015. Crossref

  88. Secret Emilie, Crannell Kelsey E., Kelly Stefan J., Villancio-Wolter Maria, Andrew Jennifer S., Matrix metalloproteinase-sensitive hydrogel microparticles for pulmonary drug delivery of small molecule drugs or proteins, Journal of Materials Chemistry B, 3, 27, 2015. Crossref

  89. Yadollahi Roya, Vasilev Krasimir, Simovic Spomenka, Nanosuspension Technologies for Delivery of Poorly Soluble Drugs, Journal of Nanomaterials, 2015, 2015. Crossref

  90. Hu Liandong, Kong Dongqian, Hu Qiaofeng, Gao Na, Pang Saixi, Evaluation of High-Performance Curcumin Nanocrystals for Pulmonary Drug Delivery Both In Vitro and In Vivo, Nanoscale Research Letters, 10, 1, 2015. Crossref

  91. Stocke Nathanael A., Arnold Susanne M., Zach Hilt J., Responsive hydrogel nanoparticles for pulmonary delivery, Journal of Drug Delivery Science and Technology, 29, 2015. Crossref

  92. Moreno-Sastre M., Pastor M., Salomon C. J., Esquisabel A., Pedraz J. L., Pulmonary drug delivery: a review on nanocarriers for antibacterial chemotherapy, Journal of Antimicrobial Chemotherapy, 70, 11, 2015. Crossref

  93. SOUZA CLAUDIA REGINA FERNANDE DE, BALDIM IARA, OLIVEIRA WANDERLEY PEREIRA DE, SPRAY DRYING DE DISPERSÕES LIPÍDICAS CONTENDO ANTIOXIDANTES NATURAIS, Anais do XXXVII Congresso Brasileiro de Sistemas Particulados, 2015. Crossref

  94. Kumar M, Domb A, Drug Delivery, Controlled, in Encyclopedia of Biomaterials and Biomedical Engineering, Second Edition - Four Volume Set, 2008. Crossref

  95. El-Sherbiny Ibrahim M., El-Baz Nancy M., Yacoub Magdi H., Inhaled nano- and microparticles for drug delivery, Global Cardiology Science and Practice, 2015, 1, 2015. Crossref

  96. Paramjot , Khan Nikhat Mansoor, Kapahi Himani, Kumar Sahil, Bhardwaj T. R., Arora Saahil, Mishra Neeraj, Role of polymer–drug conjugates in organ-specific delivery systems, Journal of Drug Targeting, 23, 5, 2015. Crossref

  97. Mansour Heidi M., Rhee Yun-Seok, Park Chun-Woong, DeLuca Patrick P., LIPID NANOPARTICULATE DRUG DELIVERY AND NANOMEDICINE, in Lipids in Nanotechnology, 2012. Crossref

  98. Kurmi Balak D, Kayat Jitendra, Gajbhiye Virendra, Tekade Rakesh K, Jain Narendra K, Micro- and nanocarrier-mediated lung targeting, Expert Opinion on Drug Delivery, 7, 7, 2010. Crossref

  99. Alavi Sonia, Haeri Azadeh, Dadashzadeh Simin, Utilization of chitosan-caged liposomes to push the boundaries of therapeutic delivery, Carbohydrate Polymers, 157, 2017. Crossref

  100. Baldelli Alberto, Vehring Reinhard, Analysis of cohesion forces between monodisperse microparticles with rough surfaces, Colloids and Surfaces A: Physicochemical and Engineering Aspects, 506, 2016. Crossref

  101. Surasarang Soraya Hengsawas, Williams Robert O., Pharmaceutical Cryogenic Technologies, in Formulating Poorly Water Soluble Drugs, 22, 2016. Crossref

  102. Singh Ashok K., Principles of Nanotoxicology, in Engineered Nanoparticles, 2016. Crossref

  103. Park Jae Hyung, Saravanakumar Gurusamy, Kim Kwangmeyung, Kwon Ick Chan, Targeted delivery of low molecular drugs using chitosan and its derivatives, Advanced Drug Delivery Reviews, 62, 1, 2010. Crossref

  104. Gao Yuan, Bai Yuntong, Zhao Ding, Chang Ming-Wei, Ahmad Zeeshan, Li Jing-Song, Tuning Microparticle Porosity during Single Needle Electrospraying Synthesis via a Non-Solvent-Based Physicochemical Approach, Polymers, 7, 12, 2015. Crossref

  105. Lin Hong-Ru, Li Yu-Sheng, Lin Yiu-Jiuan, Novel microencapsulated Pluronic–chitosan nanomicelles for lung delivery, Colloid and Polymer Science, 294, 7, 2016. Crossref

  106. Restani Rita B., Silva A. Sofia, Pires Rita F., Cabral Renato, Correia Ilídio J., Casimiro Teresa, Bonifácio Vasco D. B., Aguiar-Ricardo Ana, Nano-in-Micro POxylated Polyurea Dendrimers and Chitosan Dry Powder Formulations for Pulmonary Delivery, Particle & Particle Systems Characterization, 33, 11, 2016. Crossref

  107. Pallagi Edina, Karimi Keyhaneh, Ambrus Rita, Szabó-Révész Piroska, Csóka Ildikó, New aspects of developing a dry powder inhalation formulation applying the quality-by-design approach, International Journal of Pharmaceutics, 511, 1, 2016. Crossref

  108. Misra Ambikanandan, Jinturkar Kaustubh, Patel Deepa, Lalani Jigar, Chougule Mahavir, Recent advances in liposomal dry powder formulations: preparation and evaluation, Expert Opinion on Drug Delivery, 6, 1, 2009. Crossref

  109. Singh Namita Ashish, Nanotechnology Definitions, Research, Industry and Property Rights, in Nanoscience in Food and Agriculture 1, 20, 2016. Crossref

  110. Xi Jinxiang, Wang Zhaoxuan, Nevorski Danielle, White Thomas, Zhou Yue, Nasal and Olfactory Deposition with Normal and Bidirectional Intranasal Delivery Techniques:In VitroTests and Numerical Simulations, Journal of Aerosol Medicine and Pulmonary Drug Delivery, 30, 2, 2017. Crossref

  111. Sherwood Jill K., Alex Sony, Salama Germain, Obenauer-Kutner Linda, Huyck Susan, Berry Julianne, Sequeira Joel, Brouet Guillaume, Marie Christophe, Particle Size Coarsening Induced by Valve Silicone in a Metered Dose Inhaler, Drug Development and Industrial Pharmacy, 33, 2, 2007. Crossref

  112. Ni Rui, Zhao Jing, Liu Qiaoyu, Liang Zhenglin, Muenster Uwe, Mao Shirui, Nanocrystals embedded in chitosan-based respirable swellable microparticles as dry powder for sustained pulmonary drug delivery, European Journal of Pharmaceutical Sciences, 99, 2017. Crossref

  113. Sato Hideyuki, Suzuki Hiroki, Yakushiji Keisuke, Wong Jennifer, Seto Yoshiki, Prud’homme Robert K., Chan Hak-Kim, Onoue Satomi, Biopharmaceutical Evaluation of Novel Cyclosporine A Nano-matrix Particles for Inhalation, Pharmaceutical Research, 33, 9, 2016. Crossref

  114. Baldelli Alberto, Power Rory M., Miles Rachael E. H., Reid Jonathan P., Vehring Reinhard, Effect of crystallization kinetics on the properties of spray dried microparticles, Aerosol Science and Technology, 50, 7, 2016. Crossref

  115. Haque Shadabul, Whittaker Michael R., McIntosh Michelle P., Pouton Colin W., Kaminskas Lisa M., Disposition and safety of inhaled biodegradable nanomedicines: Opportunities and challenges, Nanomedicine: Nanotechnology, Biology and Medicine, 12, 6, 2016. Crossref

  116. Triolo D., Craparo E.F., Porsio B., Fiorica C., Giammona G., Cavallaro G., Polymeric drug delivery micelle-like nanocarriers for pulmonary administration of beclomethasone dipropionate, Colloids and Surfaces B: Biointerfaces, 151, 2017. Crossref

  117. Adi Handoko, Young Paul Michael, Chan Hak-Kim, Salama Rania, Traini Daniela, Controlled release antibiotics for dry powder lung delivery, Drug Development and Industrial Pharmacy, 36, 1, 2010. Crossref

  118. Colvin Vicki L, The potential environmental impact of engineered nanomaterials, Nature Biotechnology, 21, 10, 2003. Crossref

  119. Huang Y. C., Vieira A., Yeh M. K., Chiang C. H., Pulmonary Anti-inflammatory Effects of Chitosan Microparticles Containing Betamethasone, Journal of Bioactive and Compatible Polymers, 22, 1, 2007. Crossref

  120. Ni Rui, Muenster Uwe, Zhao Jing, Zhang Lan, Becker-Pelster Eva-Maria, Rosenbruch Martin, Mao Shirui, Exploring polyvinylpyrrolidone in the engineering of large porous PLGA microparticles via single emulsion method with tunable sustained release in the lung: In vitro and in vivo characterization, Journal of Controlled Release, 249, 2017. Crossref

  121. Yildiz-Pekoz Ayca, Ozsoy Yildiz, Inhaled Heparin: Therapeutic Efficacy and Recent Formulations, Journal of Aerosol Medicine and Pulmonary Drug Delivery, 30, 3, 2017. Crossref

  122. Marianecci Carlotta, Marzio Luisa Di, Rinaldi Federica, Carafa Maria, Alhaique Franco, Pulmonary Delivery: Innovative Approaches and Perspectives, Journal of Biomaterials and Nanobiotechnology, 02, 05, 2011. Crossref

  123. Fischer Nicholas O., Weilhammer Dina R., Dunkle Alexis, Thomas Cynthia, Hwang Mona, Corzett Michele, Lychak Cheri, Mayer Wasima, Urbin Salustra, Collette Nicole, Chiun Chang Jiun, Loots Gabriela G., Rasley Amy, Blanchette Craig D., Ceña Valentin, Evaluation of Nanolipoprotein Particles (NLPs) as an In Vivo Delivery Platform, PLoS ONE, 9, 3, 2014. Crossref

  124. Hughes Gareth A., Chapter 2: Nanostructure‒Mediated Drug Delivery, in Nanomedicine in Cancer, 2017. Crossref

  125. Kulkarni Abhijeet D., Joshi Aditya A., Patil Chirag L., Amale Prasad D., Patel Harun M., Surana Sanjay J., Belgamwar Veena S., Chaudhari Kapil S., Pardeshi Chandrakantsing V., Xyloglucan: A functional biomacromolecule for drug delivery applications, International Journal of Biological Macromolecules, 104, 2017. Crossref

  126. Xi Jinxiang, Yang Tiancheng, Talaat Khaled, Wen Tianshu, Zhang Yu, Klozik Scott, Peters Shannon, Visualization of local deposition of nebulized aerosols in a human upper respiratory tract model, Journal of Visualization, 21, 2, 2018. Crossref

  127. Lu Jun, Xi Jinxiang, Langenderfer Joseph E., Sensitivity Analysis and Uncertainty Quantification in Pulmonary Drug Delivery of Orally Inhaled Pharmaceuticals, Journal of Pharmaceutical Sciences, 106, 11, 2017. Crossref

  128. Khan M. Shahnawaz, Pandey Sunil, Bhaisare Mukesh L., Gedda Gangaraju, Talib Abou, Wu Hui-Fen, Graphene oxide@gold nanorods for chemo-photothermal treatment and controlled release of doxorubicin in mice Tumor, Colloids and Surfaces B: Biointerfaces, 160, 2017. Crossref

  129. Zhang Jiuhong, Xie Zhiqiang, Zhang Nan, Zhong Jian, Nanosuspension drug delivery system: preparation, characterization, postproduction processing, dosage form, and application, in Nanostructures for Drug Delivery, 2017. Crossref

  130. Wang Qiyue, Mi Gujie, Hickey Daniel, Li Yanan, Tu Jiasheng, Webster Thomas J., Shen Yan, Azithromycin-loaded respirable microparticles for targeted pulmonary delivery for the treatment of pneumonia, Biomaterials, 160, 2018. Crossref

  131. Pardeshi Chandrakantsing V., Kulkarni Abhijeet D., Belgamwar Veena S., Surana Sanjay J., Xyloglucan for drug delivery applications, in Fundamental Biomaterials: Polymers, 2018. Crossref

  132. Selvam Parthiban, El-Sherbiny Ibrahim M., Smyth Hugh D.C., Swellable Hydrogel Particles for Controlled Release Pulmonary Administration Using Propellant-Driven Metered Dose Inhalers, Journal of Aerosol Medicine and Pulmonary Drug Delivery, 24, 1, 2011. Crossref

  133. Joshi N., Nanotechnology Enabled Inhalation of Bio-therapeutics for Pulmonary Diseases: Design Considerations and Challenges, Current Pathobiology Reports, 6, 4, 2018. Crossref

  134. Guan Jing, Cheng Peng, Huang Shu Jie, Li Zhi Hong, Zhang Xi Zheng, Wu Ji Min, Guo Yong, Li Rui Xin, Study on Preparation of Chitosan Microspheres Loaded with Levofloxacin, Key Engineering Materials, 609-610, 2014. Crossref

  135. Poh Tuang Yeow, Ali Nur A’tikah Binte Mohamed, Mac Aogáin Micheál, Kathawala Mustafa Hussain, Setyawati Magdiel Inggrid, Ng Kee Woei, Chotirmall Sanjay Haresh, Inhaled nanomaterials and the respiratory microbiome: clinical, immunological and toxicological perspectives, Particle and Fibre Toxicology, 15, 1, 2018. Crossref

  136. Price Dominique N., Muttil Pavan, Delivery of Therapeutics to the Lung, in Lung Innate Immunity and Inflammation, 1809, 2018. Crossref

  137. Zhang Xuejuan, Zhao Ziyu, Cui Yingtong, Liu Fei, Huang Zhengwei, Huang Ying, Zhang Rui, Freeman Tim, Lu Xiangyun, Pan Xin, Tan Wen, Wu Chuanbin, Effect of powder properties on the aerosolization performance of nanoporous mannitol particles as dry powder inhalation carriers, Powder Technology, 358, 2019. Crossref

  138. da Rocha Sandro R. P., Bharatwaj Balaji, Saiprasad Sowmya, Science and Technology of Pressurized Metered-Dose Inhalers, in Controlled Pulmonary Drug Delivery, 2011. Crossref

  139. Abdelaal Ahmed Mahmoud Ahmed, Mahmoud Hatem Elmoutaz, Mahran Mohamed Ali, Khaled Marwa, Streptokinase Versus Unfractionated Heparin Nebulization in Patients With Severe Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial With Observational Controls, Journal of Cardiothoracic and Vascular Anesthesia, 34, 2, 2020. Crossref

  140. Sheth Poonam, Myrdal Paul B., Polymers for Pulmonary Drug Delivery, in Controlled Pulmonary Drug Delivery, 2011. Crossref

  141. Nguyen Hiep X., Targeted Delivery of Surface-Modified Nanoparticles: Modulation of Inflammation for Acute Lung Injury, in Surface Modification of Nanoparticles for Targeted Drug Delivery, 2019. Crossref

  142. Athamneh Tamara, Amin Adil, Benke Edit, Ambrus Rita, Leopold Claudia S., Gurikov Pavel, Smirnova Irina, Alginate and hybrid alginate-hyaluronic acid aerogel microspheres as potential carrier for pulmonary drug delivery, The Journal of Supercritical Fluids, 150, 2019. Crossref

  143. Shoyele Sunday A., Controlling the Release of Proteins/Peptides via the Pulmonary Route, in Drug Delivery Systems, 437, 2008. Crossref

  144. Kumar Deepak, Pal Samanwita, Optical band gap and crystallite size investigations of anticancer drug loaded ZnO nanoparticles, ADVANCES IN BASIC SCIENCE (ICABS 2019), 2142, 2019. Crossref

  145. Pinto Carneiro Simone, Moine Laurence, Tessier Barbara, Nicolas Valerie, dos Santos Orlando, Fattal Elias, Pyrazinoic acid-Poly(malic acid) biodegradable nanoconjugate for efficient intracellular delivery, Precision Nanomedicine, 2, 3, 2019. Crossref

  146. Karimian Ramin, Aghajani Milad, Cyclodextrins and their Derivatives as Carrier Molecules in Drug and Gene Delivery Systems, Current Organic Chemistry, 23, 11, 2019. Crossref

  147. Leynen Nathalie, Van Belleghem Frank G.A.J, Wouters Annelies, Bove Hannelore, Ploem Jan-Pieter, Thijssen Elsy, Langie Sabine A.S., Carleer Robert, Ameloot Marcel, Artois Tom, Smeets Karen, In vivo Toxicity Assessment of Silver Nanoparticles in Homeostatic versus Regenerating Planarians, Nanotoxicology, 13, 4, 2019. Crossref

  148. Shah Muhammad Raza, Imran Muhammad, Ullah Shafi, Nanocarrier-based targeted pulmonary delivery: novel approaches for effective lung cancer treatment, in Nanocarriers for Cancer Diagnosis and Targeted Chemotherapy, 2019. Crossref

  149. Yang Wei, Owens Donald E., Williams Robert O., Pharmaceutical Cryogenic Technologies, in Formulating Poorly Water Soluble Drugs, 3, 2012. Crossref

  150. Beck-Broichsitter Moritz, Dalla-Bona Alexandra C., Kissel Thomas, Seeger Werner, Schmehl Thomas, Polymer Nanoparticle-Based Controlled Pulmonary Drug Delivery, in Drug Delivery System, 1141, 2014. Crossref

  151. Sankhe Kaksha, Khan Tabassum, Bhavsar Chintan, Momin Munira, Omri Abdelwahab, Selective drug deposition in lungs through pulmonary drug delivery system for effective management of drug-resistant TB, Expert Opinion on Drug Delivery, 16, 5, 2019. Crossref

  152. Kong Dexuan, Ren Chang, Ning Chen, Cheng Yujie, Cai Hui, Xing Han, Zhang Yongjie, Li Ning, Lu Yang, Chen Xijing, Zhao Di, Pulmonary administration of resveratrol/hydroxypropyl-β-cyclodextrin inclusion complex: in vivo disposition and in vitro metabolic study, Journal of Drug Delivery Science and Technology, 60, 2020. Crossref

  153. Chaurasiya Birendra, Zhao You-Yang, Dry Powder for Pulmonary Delivery: A Comprehensive Review, Pharmaceutics, 13, 1, 2020. Crossref

  154. Agnihotri Vinit V., Pardeshi Chandrakantsing V., Surana Sanjay J., A current update on advanced drug delivery devices for nasal and pulmonary administration, in Drug Delivery Devices and Therapeutic Systems, 2021. Crossref

  155. Xi Jinxiang, Talaat Mohamed, Si Xiuhua April, Chandra Shekhar, The application of statistical shape modeling for lung morphology in aerosol inhalation dosimetry, Journal of Aerosol Science, 151, 2021. Crossref

  156. Mohammady Mohsen, mohammadi Yasaman, Yousefi Gholamhossein, Freeze-Drying of Pharmaceutical and Nutraceutical Nanoparticles: The Effects of Formulation and Technique Parameters on Nanoparticles Characteristics, Journal of Pharmaceutical Sciences, 109, 11, 2020. Crossref

  157. Douafer Hana, Andrieu Véronique, Brunel Jean Michel, Scope and limitations on aerosol drug delivery for the treatment of infectious respiratory diseases, Journal of Controlled Release, 325, 2020. Crossref

  158. Awad Atheer, Madla Christine M., Gavins Francesca K.H., Allahham Nour, Trenfield Sarah J., Basit Abdul W., Liquid dosage forms, in Remington, 2021. Crossref

  159. Merkel Olivia M., Zheng Mengyao, Debus Heiko, Kissel Thomas, Pulmonary Gene Delivery Using Polymeric Nonviral Vectors, Bioconjugate Chemistry, 23, 1, 2012. Crossref

  160. Gulzar Saqib, Benjakul Soottawat, Nanoliposome Powder Containing Shrimp Oil Increases Free Flowing Behavior and Storage Stability, European Journal of Lipid Science and Technology, 122, 6, 2020. Crossref

  161. Rahamim Valeria, Azagury Aharon, Bioengineered Biomimetic and Bioinspired Noninvasive Drug Delivery Systems, Advanced Functional Materials, 31, 44, 2021. Crossref

  162. Peguin Robson P. S., Wu Libo, da Rocha Sandro R. P., The Ester Group:  How Hydrofluoroalkane-philic Is It?, Langmuir, 23, 16, 2007. Crossref

  163. Joshi Nitin, Can nanotechnology hit the spot in aerosol-based drug delivery for lung disorders?, Therapeutic Delivery, 9, 4, 2018. Crossref

  164. Li Jingjing, Zhang Kai, Wu Di, Ren Lianjie, Chu Xinyu, Qin Chao, Han Xiaopeng, Hang Taijun, Xu Yungen, Yang Lei, Yin Lifang, Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19, Asian Journal of Pharmaceutical Sciences, 16, 6, 2021. Crossref

  165. Fernández-Paz Cristina, Rojas Sara, Salcedo-Abraira Pablo, Simón-Yarza Teresa, Remuñán-López Carmen, Horcajada Patricia, Metal–Organic Framework Microsphere Formulation for Pulmonary Administration, ACS Applied Materials & Interfaces, 12, 23, 2020. Crossref

  166. Bohr Adam, Beck-Broichsitter Moritz, Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems, Therapeutic Delivery, 6, 5, 2015. Crossref

  167. Eriksson Johanna, Thörn Helena, Sjögren Erik, Holmstén Lisa, Rubin Katarina, Lennernäs Hans, Pulmonary Dissolution of Poorly Soluble Compounds Studied in an ex Vivo Rat Lung Model, Molecular Pharmaceutics, 16, 7, 2019. Crossref

  168. Das Pranab Jyoti, Paul Paramita, Mukherjee Biswajit, Mazumder Bhaskar, Mondal Laboni, Baishya Rinku, Debnath Mita Chatterjee, Dey Kumar Saurav, Pulmonary Delivery of Voriconazole Loaded Nanoparticles Providing a Prolonged Drug Level in Lungs: A Promise for Treating Fungal Infection, Molecular Pharmaceutics, 12, 8, 2015. Crossref

  169. Wu Libo, da Rocha Sandro R. P., Nanoparticle-Stabilized Colloids in Compressible Hydrofluoroalkanes, Langmuir, 27, 17, 2011. Crossref

  170. Zhang Man, Ye Lili, Huang Hao, Cheng Dandan, Liu Kaixin, Wu Wenbo, Shen Fukui, Jiang Zhihong, Hou Yuanyuan, Bai Gang, Micelles self-assembled by 3-O-β-d-glucopyranosyl latycodigenin enhance cell membrane permeability, promote antibiotic pulmonary targeting and improve anti-infective efficacy, Journal of Nanobiotechnology, 18, 1, 2020. Crossref

  171. Elkady Omar A., Saleh Layla M., Tadros Mina Ibrahim, El-laithy Hanan M., Nebulization of Risedronate Sodium Microspheres for Potential Attenuation of Pulmonary Emphysema: a Promising New Insight of Alveolar Macrophage Apoptosis, AAPS PharmSciTech, 22, 5, 2021. Crossref

  172. Dastidar Debabrata Ghosh, Ghosh Dipanjan, Ghosh Swarnasree, Chakrabarti Gopal, Drug Delivery in Respiratory Diseases: Current Opportunities, Molecular and Cellular Mechanism, and Future Challenges, in Targeting Cellular Signalling Pathways in Lung Diseases, 2021. Crossref

  173. Wu Libo, da Rocha Sandro R. P., Biocompatible and Biodegradable Copolymer Stabilizers for Hydrofluoroalkane Dispersions:  A Colloidal Probe Microscopy Investigation, Langmuir, 23, 24, 2007. Crossref

  174. Tayeb Hossam H, Sainsbury Frank, Nanoemulsions in drug delivery: formulation to medical application, Nanomedicine, 13, 19, 2018. Crossref

  175. Ramsey Joanne M, Hibbitts Alan, Barlow James, Kelly Ciara, Sivadas Neeraj, Cryan Sally-Ann, ‘Smart’ non-viral delivery systems for targeted delivery of RNAi to the lungs, Therapeutic Delivery, 4, 1, 2013. Crossref

  176. Pirooznia Nazanin, Hasannia Sadegh, Arab Seyed Shahriar, Lotfi Abbas Sahebghadam, Ghanei Mostafa, Shali Abbas, The design of a new truncated and engineered alpha1-antitrypsin based on theoretical studies: an antiprotease therapeutics for pulmonary diseases, Theoretical Biology and Medical Modelling, 10, 1, 2013. Crossref

  177. Grenha Ana, Seijo Begoña, Serra Carmen, Remuñán-López Carmen, Chitosan Nanoparticle-Loaded Mannitol Microspheres:  Structure and Surface Characterization, Biomacromolecules, 8, 7, 2007. Crossref

  178. Selvam Parthiban, Peguin Robson P. S., Chokshi Udayan, da Rocha Sandro R. P., Surfactant Design for the 1,1,1,2-Tetrafluoroethane−Water Interface:  ab initio Calculations and in situ High-Pressure Tensiometry, Langmuir, 22, 21, 2006. Crossref

  179. Benke Edit, Varga Patrícia, Szabó-Révész Piroska, Ambrus Rita, Stability and In Vitro Aerodynamic Studies of Inhalation Powders Containing Ciprofloxacin Hydrochloride Applying Different DPI Capsule Types, Pharmaceutics, 13, 5, 2021. Crossref

  180. Gandhi Himanshu, Mahant Shikha, Bansal Amit, Kapoor Deepak N., Targeting Chronic Lung Diseases Using Advanced Drug Delivery Systems, in Targeting Cellular Signalling Pathways in Lung Diseases, 2021. Crossref

  181. Selvakani Prabakaran, Murugan Sumathra, Rajan Mariappan, The pulmonary administration route: Advantages and challenges, in A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy, 2021. Crossref

  182. Sousa Flávia, Castro Pedro, Fonte Pedro, Sarmento Bruno, How to overcome the limitations of current insulin administration with new non-invasive delivery systems, Therapeutic Delivery, 6, 1, 2015. Crossref

  183. Xu Xiuan, Zhang Ruixin, Liu Fang, Ping Jiaqi, Wen Xiaofei, Wang Hongbin, Wang Kai, Sun Xilin, Zou Hongyan, Shen Baozhong, Wu Lina, 19F MRI in orthotopic cancer model via intratracheal administration of ανβ3-targeted perfluorocarbon nanoparticles, Nanomedicine, 13, 20, 2018. Crossref

  184. Guo Yi, Bera Hriday, Shi Changzhi, Zhang Li, Cun Dongmei, Yang Mingshi, Pharmaceutical strategies to extend pulmonary exposure of inhaled medicines, Acta Pharmaceutica Sinica B, 11, 8, 2021. Crossref

  185. Zhong Wenhao, Zhang Xinyu, Zeng Yunxin, Lin Dongjun, Wu Jun, Recent applications and strategies in nanotechnology for lung diseases, Nano Research, 14, 7, 2021. Crossref

  186. Lim Young H., Tiemann Kristin M., Hunstad David A., Elsabahy Mahmoud, Wooley Karen L., Polymeric nanoparticles in development for treatment of pulmonary infectious diseases, WIREs Nanomedicine and Nanobiotechnology, 8, 6, 2016. Crossref

  187. Ahmad Mohammad Zaki, Ahmad Javed, Aslam Mohammed, Khan Mohammad Ahmed, Alasmary Mohammed Yahia, Abdel-Wahab Basel A, Repurposed drug against COVID-19: nanomedicine as an approach for finding new hope in old medicines, Nano Express, 2, 2, 2021. Crossref

  188. Kankala Ranjith Kumar, Lin Xiao-Fen, Song Hu-Fan, Wang Shi-Bin, Yang Da-Yun, Zhang Yu Shrike, Chen Ai-Zheng, Supercritical Fluid-Assisted Decoration of Nanoparticles on Porous Microcontainers for Codelivery of Therapeutics and Inhalation Therapy of Diabetes, ACS Biomaterials Science & Engineering, 4, 12, 2018. Crossref

  189. Manca Maria Letizia, Ferraro Maria, Pace Elisabetta, Di Vincenzo Serena, Valenti Donatella, Fernàndez-Busquets Xavier, Peptu Catalina Anisoara, Manconi Maria, Loading of Beclomethasone in Liposomes and Hyalurosomes Improved with Mucin as Effective Approach to Counteract the Oxidative Stress Generated by Cigarette Smoke Extract, Nanomaterials, 11, 4, 2021. Crossref

  190. Lin Ling, Zhou Yixian, Quan Guilan, Pan Xin, Wu Chuanbin, The rough inhalable ciprofloxacin hydrochloride microparticles based on silk fibroin for non-cystic fibrosis bronchiectasis therapy with good biocompatibility, International Journal of Pharmaceutics, 607, 2021. Crossref

  191. Daman Zahra, Gilani Kambiz, Rouholamini Najafabadi Abdolhossein, Eftekhari Hamid Reza, Barghi Mohammad Ali, Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique, DARU Journal of Pharmaceutical Sciences, 22, 1, 2014. Crossref

  192. Secret Emilie, Kelly Stefan J., Crannell Kelsey E., Andrew Jennifer S., Enzyme-Responsive Hydrogel Microparticles for Pulmonary Drug Delivery, ACS Applied Materials & Interfaces, 6, 13, 2014. Crossref

  193. Carvalho Edison L.S., Grenha Ana, Remuñán-López Carmen, Alonso Maria José, Seijo Begoña, , 465, 2009. Crossref

  194. Si Xiuhua April, Xi Jinxiang, Computer-Aided Development and Testing of Human Extra-Thoracic Airway Models for Inhalation Drug Delivery, in Computer Aided Pharmaceutics and Drug Delivery, 2022. Crossref

  195. Shah Muhammad Raza, Imran Muhammad, Ullah Shafi, Improved pulmonary drug delivery through nanocarriers, in Nanocarriers for Organ-Specific and Localized Drug Delivery, 2022. Crossref

  196. Sahakijpijarn Sawittree, Moon Chaeho, Williams Robert O., Pharmaceutical Cryogenic Technologies, in Formulating Poorly Water Soluble Drugs, 50, 2022. Crossref

  197. Kurmi Balak D., Gajbhiye Virendra, Kayat Jitendra, Jain Narendra K., Lactoferrin-Conjugated Dendritic Nanoconstructs for Lung Targeting of Methotrexate, Journal of Pharmaceutical Sciences, 100, 6, 2011. Crossref

  198. Hajrasouliha Amir Reza, Jiang Guomin, Lu Qingxian, Lu Huayi, Kaplan Henry J., Zhang Huang-Ge, Shao Hui, Exosomes from Retinal Astrocytes Contain Antiangiogenic Components That Inhibit Laser-induced Choroidal Neovascularization, Journal of Biological Chemistry, 288, 39, 2013. Crossref

  199. Fernández-Paz Estefanía, Fernández-Paz Cristina, Barrios-Esteban Sheila, Santalices Irene, Csaba Noemi, Remuñán-López Carmen, Dry powders containing chitosan-based nanocapsules for pulmonary administration: Adjustment of spray-drying process and in vitro evaluation in A549 cells, Powder Technology, 399, 2022. Crossref

  200. Fonte Pedro, Reis Salette, Sarmento Bruno, Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery, Journal of Controlled Release, 225, 2016. Crossref

  201. Shi Xiaozheng, Li Chunjie, Gao Sai, Zhang Lingfei, Han Haobo, Zhang Jianxu, Shi Wei, Li Quanshun, Combination of doxorubicin-based chemotherapy and polyethylenimine/p53 gene therapy for the treatment of lung cancer using porous PLGA microparticles, Colloids and Surfaces B: Biointerfaces, 122, 2014. Crossref

  202. Blank Fabian, Stumbles Philip A., Seydoux Emilie, Holt Patrick G., Fink Alke, Rothen-Rutishauser Barbara, Strickland Deborah H., von Garnier Christophe, Size-Dependent Uptake of Particles by Pulmonary Antigen-Presenting Cell Populations and Trafficking to Regional Lymph Nodes, American Journal of Respiratory Cell and Molecular Biology, 49, 1, 2013. Crossref

  203. Xia Yun, Su Yipeng, Wang Qiyue, Yang Chen, Tang Baoqiang, Zhang Yue, Tu Jiasheng, Shen Yan, Preparation, characterization, and pharmacodynamics of insulin-loaded fumaryl diketopiperazine microparticle dry powder inhalation, Drug Delivery, 26, 1, 2019. Crossref

  204. Praphawatvet Tuangrat, Peters Jay I., Williams Robert O., Inhaled nanoparticles–An updated review, International Journal of Pharmaceutics, 587, 2020. Crossref

  205. Nikolaou Maria, Avraam Kyriakos, Kolokithas-Ntoukas Argiris, Bakandritsos Aristides, Lizal Frantisek, Misik Ondrej, Maly Milan, Jedelsky Jan, Savva Ioanna, Balanean Florica, Krasia-Christoforou Theodora, Superparamagnetic electrospun microrods for magnetically-guided pulmonary drug delivery with magnetic heating, Materials Science and Engineering: C, 126, 2021. Crossref

  206. Li Nan, Weng Dong, Wang Shan-Mei, Zhang Yuan, Chen Shan-Shan, Yin Zhao-Fang, Zhai Jiali, Scoble Judy, Williams Charlotte C., Chen Tao, Qiu Hui, Wu Qin, Zhao Meng-Meng, Lu Li-Qin, Mulet Xavier, Li Hui-Ping, Surfactant protein-A nanobody-conjugated liposomes loaded with methylprednisolone increase lung-targeting specificity and therapeutic effect for acute lung injury, Drug Delivery, 24, 1, 2017. Crossref

  207. Meng Linlin, Liao Ximing, Wang Yuanyuan, Chen Liangzhi, Gao Wei, Wang Muyun, Dai Huiling, Yan Na, Gao Yixuan, Wu Xu, Wang Kun, Liu Qinghua, Pharmacologic therapies of ARDS: From natural herb to nanomedicine, Frontiers in Pharmacology, 13, 2022. Crossref

  208. Zawar Laxmikant, Patil Gaurav, Shirsath Nitin, Bafna Piyush, Nanosuspension: A New Horizon in the Drug Delivery System, International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN), 15, 5, 2022. Crossref

  209. Tang Jie, Ouyang Qiuhong, Li Yanyan, Zhang Peisen, Jin Weihua, Qu Shuang, Yang Fengmei, He Zhanlong, Qin Meng, Nanomaterials for Delivering Antibiotics in the Therapy of Pneumonia, International Journal of Molecular Sciences, 23, 24, 2022. Crossref

Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa Políticas de preços e assinaturas Begell House Contato Language English 中文 Русский Português German French Spain